Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, October 25, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Elucid Raises $80 Million in Series C Round Led by Elevage Medical Technologies
Life Sciences Times
-
November 9, 2023
0
Venture Capital
Cromatic Closes $5.3 Million in Oversubscribed Seed Round to Modernize Life Science R&D Outsourcing
Life Sciences Times
-
November 9, 2023
0
Venture Capital
Everest Clinical Research Announces the Acquisition of August Research
Life Sciences Times
-
November 7, 2023
0
Venture Capital
OrsoBio Announces $60M Series A Financing to Advance Metabolic Portfolio for the Treatment of Obesity and Associated Disorders
Life Sciences Times
-
November 7, 2023
0
Venture Capital
Click Therapeutics Secures $20 Million Debt Financing from HSBC
Life Sciences Times
-
November 6, 2023
0
Venture Capital
Terremoto Biosciences Closes $175 Million Series B Financing
Life Sciences Times
-
November 2, 2023
0
Venture Capital
Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
Life Sciences Times
-
November 2, 2023
0
Venture Capital
Aktana Acquires Tact.ai’s Field Engagement and Conversational AI Technology
Life Sciences Times
-
November 1, 2023
0
Venture Capital
Bioluminescence Ventures Emerges from Stealth with $477M AUM
Life Sciences Times
-
November 1, 2023
0
Venture Capital
Ligand Acquires Royalty on Sanofi’s TZIELD® for $20 Million
Life Sciences Times
-
November 1, 2023
0
Venture Capital
ORO Labs Raises $34M Series B to Humanize Procurement in Round Led by Felicis
Life Sciences Times
-
November 1, 2023
0
Venture Capital
Daicel Group Invests in PharmaJet
Life Sciences Times
-
October 31, 2023
0
1
...
38
39
40
...
115
Page 39 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026